KR870007163A - 질소함유 융합 헤테로 사이클릭 화합물의 제조방법 - Google Patents
질소함유 융합 헤테로 사이클릭 화합물의 제조방법 Download PDFInfo
- Publication number
- KR870007163A KR870007163A KR870000328A KR870000328A KR870007163A KR 870007163 A KR870007163 A KR 870007163A KR 870000328 A KR870000328 A KR 870000328A KR 870000328 A KR870000328 A KR 870000328A KR 870007163 A KR870007163 A KR 870007163A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- salt
- prepared
- structural formula
- following structural
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 다음의 공정으로 다음 구조식을 갖는 화합물 또는 그 약학적으로 사용 가능한 염을 제조하는 방법 :상기 식에서.R1과 R2는 같거나 다르며, 각각 수소, 할로겐, 아릴, 저급알킬, 할로(저급)알킬 또는 니트로,R3는 저급알킬렌,R4와 R5는 같거나 다르며, 각각 저급알킬렌,X는 CH 또는 N,Y는 S,O,NH, C=N-OH 또는 CO,Z는 O 또는 NH이고,A는 수소, 니트로조, 아미디노, 다음의 기상기 식에서,R6과 R7은 같거나 다르며, 각각 수소, 저급알킬, 아실, 에스테르화 카르복시 치환 또는 비치환의 저급 알칸이미도일, 또는 다음의 기 : -N=R8상기 식에서,R8은 적절한 치환체(들)로 임의로 치환될 아릴로 치환할 수도 있는 저급알킬리덴이다.(1) 다음 구조식을 갖는 화합물이나그 카르복시기에서의 반응성 유도체 또는 그 염을, 다음 구조식을 갖는 화합물이나그 아미노기에서의 반응성 유도체, 또는 그 염과 반응시켜 다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y,Z와 A는 전술된 바와 같다.(2) 다음 구조식을 갖는 화합물또는 그 염을 니트로조화 반응시켜 다음 구조식의 화합물,또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술될 바와 같다.(3) 다음 구조식을 갖는 화합물또는 그 염을 환원시켜, 다음 구조식을 갖는 화합물,또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 전술된 바와 같다.(4) 다음 구조식을 갖는 화합물또는 그 염을 아실화하여,다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 전술된 바와 같고, Ra 6은 아실이다.(5) 다음 구조식을 갖는 화합물또는 그 염을 알킬화시켜, 다음 구조식을 갖는 화합물,또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술된 바와 같고, Rb 6은 저급알킬이고, Ra 7은 수소 혹은 저급알킬이다.(6) 다음 구조식을 갖는 화합물또는 그 염을, 다음 구조식을 갖는 화합물과 반응시켜R9-CHO다음 구조식을 갖는 화합물,또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술된 바와 같고, R9는 수소, 저급알킬 또는 적절한 치환체(들)로 임의로 치환된 아릴이다.또는 그 염을 환원시켜, 다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,R9,X,Y와 Z는 각각 전술된 바와 같다.(8) 다음 구조식을 갖는 화합물또는 그 염을 가수 분해시켜, 다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술된 바와 같고, R10은 아실, R11은 수소 또는 R10과 R11이 함께 결합하여 다음의 기를 형성한 것 :=R8상기 식에서 R8은 전술된 바와 같다.(9) 다음 구조식을 갖는 화합물또는 그 염을, 다음 구조식을 가진 화합물또는 그 염과 반응시켜 다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술된 바와 같고, R12는 저급알킬이고, R13은 에스테르화 카르복시이다.(10) 다음 구조식을 갖는 화합물또는 그 염을 환원시켜, 다음 구조식을 갖는 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,R12,R13,X,Y와 Z는 전술한 바와 같다.(11) 다음 구조식을 갖는 화합물또는 그 염을 다음 구조식을 갖는 화합물또는 그 염과 반응시켜,다음 구조식의 화합물또는 그 염을 제조한다.상기 식에서,R1,R2,R3,R4,R5,X,Y와 Z는 각각 전술된 바와 같고, R14는 저급알킬티오이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868601160A GB8601160D0 (en) | 1986-01-17 | 1986-01-17 | Heterocyclic compounds |
GB8601160 | 1986-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR870007163A true KR870007163A (ko) | 1987-08-17 |
Family
ID=10591560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870000328A KR870007163A (ko) | 1986-01-17 | 1987-01-17 | 질소함유 융합 헤테로 사이클릭 화합물의 제조방법 |
Country Status (14)
Country | Link |
---|---|
US (1) | US4797399A (ko) |
EP (1) | EP0232740A1 (ko) |
JP (1) | JPS62181253A (ko) |
KR (1) | KR870007163A (ko) |
CN (1) | CN87100707A (ko) |
AU (1) | AU6762687A (ko) |
DK (1) | DK8687A (ko) |
FI (1) | FI865369A (ko) |
GB (1) | GB8601160D0 (ko) |
IL (1) | IL81172A0 (ko) |
NO (1) | NO870053L (ko) |
OA (1) | OA08462A (ko) |
PT (1) | PT84103A (ko) |
ZA (1) | ZA869748B (ko) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601366B1 (fr) * | 1986-07-10 | 1988-11-25 | Andre Buzas | Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant. |
FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
GB8714596D0 (en) * | 1987-06-22 | 1987-07-29 | Fujisawa Pharmaceutical Co | Thiazolopyridine compounds |
FR2663929A1 (fr) * | 1990-06-29 | 1992-01-03 | Adir | Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2669336B1 (fr) * | 1990-11-20 | 1993-01-22 | Adir | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
GB9602294D0 (en) * | 1996-02-05 | 1996-04-03 | Zeneca Ltd | Heterocyclic compounds |
DE19618970A1 (de) * | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Thiazolopyridine |
DE19618999A1 (de) * | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Benzothiazolinone |
DE69718177T2 (de) * | 1996-08-14 | 2003-10-23 | Astrazeneca Ab, Soedertaelje | Substituierte pyrimidinderivate und ihre pharmazeutische anwendung |
UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
ES2201438T3 (es) | 1997-02-13 | 2004-03-16 | Astrazeneca Ab | Compuestos heterociclicos utiles como inhibidores de la oxido-escualeno-ciclasa. |
JP2001511798A (ja) | 1997-02-13 | 2001-08-14 | ゼネカ・リミテッド | オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物 |
BR9810508A (pt) | 1997-07-03 | 2000-09-05 | Du Pont Pharm Co | Composto, composição farmacêutica e método de tratamento de uma desordem |
GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
KR20010030637A (ko) * | 1997-10-09 | 2001-04-16 | 후지야마 아키라 | 아미노피페라진 유도체의 신규한 제조방법 |
US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
WO2002004409A2 (en) * | 2000-07-06 | 2002-01-17 | Us Gov Health & Human Serv | Tetrahydrobenzothiazole analogues as neuroprotective agents |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
TW200508197A (en) * | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
CA2554774A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
AU2005235422B2 (en) * | 2004-04-22 | 2011-08-11 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for the treatment of sexual disorders II |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
JP2008511569A (ja) * | 2004-09-03 | 2008-04-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 注意欠如活動過多障害の治療方法 |
CA2599721A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
WO2006096434A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
EP1904182A2 (en) * | 2005-05-06 | 2008-04-02 | Boehringer Ingelheim International GmbH | Method for the treatment of drug abuse with flibanserin |
EP1888071A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of drug-induced sexual dysfunction |
EP1888070A1 (en) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Method for the treatment of sexual dysfunctions due to medical conditions |
CA2617546C (en) | 2005-08-03 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin in the treatment of obesity |
WO2007048803A1 (en) * | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
SI2021006T1 (sl) * | 2006-05-09 | 2016-01-29 | Sprout Pharmaceuticals, Inc. | Uporaba flibanserina za zdravljenje pomenopavznih motenj spolnega poželenja |
ES2336719T3 (es) | 2006-06-30 | 2010-04-15 | Boehringer Ingelheim International Gmbh | Flibanserina para el tratamiento de la incontinencia urinaria y las enfermedades relacionadas. |
US20090318469A1 (en) * | 2006-07-14 | 2009-12-24 | Boehringer Ingelheim International Gmbh | Use of Flibanserin for the Treatment of Sexual Disorders in Females |
AU2007286288A1 (en) * | 2006-08-14 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
EA200900270A1 (ru) * | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
US8686008B2 (en) * | 2007-08-16 | 2014-04-01 | The University Of Mississippi | Highly selective sigma receptor ligands |
CL2008002693A1 (es) * | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA928296A (en) * | 1967-06-05 | 1973-06-12 | Umio Suminori | N-substituted and n, n-disubstituted aminocarbonylalkyl compounds and their production |
GB1270841A (en) * | 1969-03-28 | 1972-04-19 | Fujisawa Pharmaceutical Co | Benzothiazoline derivatives |
GR65270B (en) * | 1978-10-10 | 1980-07-31 | Fujisawa Pharmaceutical Co | Isatin derivatives and processes for the preparation thereof |
US4279909A (en) * | 1980-02-13 | 1981-07-21 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic method |
JPS6015276A (ja) * | 1983-07-04 | 1985-01-25 | Nissan Motor Co Ltd | 自動車組立工程における組付部品の仕様判別方法 |
JPS6063972A (ja) * | 1983-09-17 | 1985-04-12 | Sumitomo Electric Ind Ltd | クライオスタツト |
-
1986
- 1986-01-17 GB GB868601160A patent/GB8601160D0/en active Pending
- 1986-12-23 US US06/945,853 patent/US4797399A/en not_active Expired - Fee Related
- 1986-12-29 ZA ZA869748A patent/ZA869748B/xx unknown
- 1986-12-31 FI FI865369A patent/FI865369A/fi not_active Application Discontinuation
-
1987
- 1987-01-05 IL IL81172A patent/IL81172A0/xx unknown
- 1987-01-06 NO NO870053A patent/NO870053L/no unknown
- 1987-01-08 DK DK008687A patent/DK8687A/da unknown
- 1987-01-14 PT PT84103A patent/PT84103A/pt unknown
- 1987-01-15 EP EP87100448A patent/EP0232740A1/en not_active Withdrawn
- 1987-01-16 AU AU67626/87A patent/AU6762687A/en not_active Abandoned
- 1987-01-16 OA OA59044A patent/OA08462A/xx unknown
- 1987-01-16 JP JP62008379A patent/JPS62181253A/ja active Pending
- 1987-01-17 CN CN198787100707A patent/CN87100707A/zh active Pending
- 1987-01-17 KR KR870000328A patent/KR870007163A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS62181253A (ja) | 1987-08-08 |
NO870053L (no) | 1987-07-20 |
OA08462A (fr) | 1988-07-29 |
DK8687D0 (da) | 1987-01-08 |
NO870053D0 (no) | 1987-01-06 |
FI865369A0 (fi) | 1986-12-31 |
FI865369A (fi) | 1987-07-18 |
ZA869748B (en) | 1987-08-26 |
EP0232740A1 (en) | 1987-08-19 |
GB8601160D0 (en) | 1986-02-19 |
PT84103A (en) | 1987-02-01 |
AU6762687A (en) | 1987-07-23 |
DK8687A (da) | 1987-07-18 |
US4797399A (en) | 1989-01-10 |
CN87100707A (zh) | 1987-09-02 |
IL81172A0 (en) | 1987-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR870007163A (ko) | 질소함유 융합 헤테로 사이클릭 화합물의 제조방법 | |
KR840008333A (ko) | 피리미딘 유도체의 제조방법 | |
KR870006072A (ko) | 라파마이신 전구체의 제조방법 | |
ES8700672A1 (es) | Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos. | |
ES414279A1 (es) | Procedimiento para la preparacion de 1,4-benzodiazepinas. | |
KR870003998A (ko) | 퀴나졸린 유도체류의 제조방법 | |
KR900009598A (ko) | 혈관평활근 이완작용을 가진 화합물과 그의 제조방법 | |
DK0525123T3 (da) | Antiatherosklerotiske og antithrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner | |
KR870006039A (ko) | 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물 | |
KR870002078A (ko) | 에틸렌디아민 모노아미드유도체의 제조방법 | |
IE40409B1 (en) | Novel 2,6-dusubstituted phenyl-aminoguanidine compounds | |
ES8406193A1 (es) | Procedimiento para la preparacion de nuevas 1,4-dihidropiridinas sustituidas | |
KR840006482A (ko) | 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법 | |
DE69329385D1 (de) | Thiazolin-derivate | |
KR860003259A (ko) | 벤젠-융합 복소환 화합물의 제조방법 | |
ATE78163T1 (de) | Stickstoff enthaltende heterozyklische verbindungen. | |
KR860006453A (ko) | 트리아지닐을 함유하는 스틸벤 유도체의 제조방법 | |
KR830008998A (ko) | N-치환된-아미노-아미노산의 제조방법 | |
KR840006226A (ko) | 티아트리아진 유도체의 제조방법 | |
KR840001160A (ko) | 벤조디옥산-이미다졸린 유도체의 제조방법 | |
HUT43568A (en) | Process for preparing novel 2-pyridiyl-acetic acid derivatives and pharmaceutics comprising the same | |
ES8306099A1 (es) | Un procedimiento para la preparacion de derivados de acido 2-(2-cianoetil)-2-benzoilamino-alcanoicos. | |
DE59706320D1 (de) | Flüssiges wäschestärke-konzentrat | |
SE8300432D0 (sv) | Reaktiva kanelsyraderivat for framstellning av biologiskt aktiva amider | |
KR840008004A (ko) | 트로폰 유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |